Greg Keenan

AUPH

Greg Keenan serves as SVP, Chief Medical Officer at Aurinia Pharmaceuticals Inc. (AUPH). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

4 trades

$544.1K

Net Position

Net Seller

$544.1K

Companies Traded

AUPH

Active Period

Feb 2025 – Feb 2026

4 total trades

Most Recent

Sell AUPH

Feb 2, 2026 · $167.9K

Greg Keenan's Insider Trading at Aurinia Pharmaceuticals Inc. (AUPH)

Buys

0 · $0.00

Sells

4 · $544.1K

Total Shares Bought

Total Shares Sold

52,096

AUPH Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Feb 2, 2026	Sell	11,552	$14.53	$167.9K
Aug 1, 2025	Sell	20,000	$10.50	$210.0K
Mar 7, 2025	Sell	8,305	$8.23	$68.4K
Feb 28, 2025	Sell	12,239	$8.00	$97.9K

Related Insiders

Joseph M Miller

Chief Financial Officer

AUPHSell · Feb 20, 2026

Stephen P. Robertson

EVP, General Counsel

AUPHSell · Feb 20, 2026

Peter Greenleaf

Chief Executive Officer

AUPHSell · Feb 20, 2026

Matthew Maxwell Donley

Chief Operating Officer

AUPHSell · Feb 20, 2026

Craig A Johnson

Director

AUPHSell · Nov 21, 2025

Jeffrey Allen Bailey

Director

AUPHSell · Nov 21, 2025

TANG KEVIN

Director

AUPHBuy · Aug 1, 2025

Explore More Insider Trading Data

AUPH Insider Trading Activity

View all insider trades at Aurinia Pharmaceuticals Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity